Geistlich Bio-Oss® Portfolio Expands

Geistlich Biomaterials launches a new package size of Geistlich Bio-Oss® that provides increased therapy flexibility in regenerative dentistry.


Princeton, NJ, USA – Ever since its global market debut 30 years ago, Geistlich Bio-Oss®, a bone substitute utilised in periodontal and oral surgery procedures to regenerate lost bone in the oral cavity, has demonstrated clinical efficacy, long-term implant survival rates and predictability, all backed by scientific publications and investigations. “Geistlich Bio-Oss® 1g meets the need for an extended product range, and additional flexibility in Guided Bone Regeneration (GBR) therapy for excellent long-term outcomes and stable aesthetic results,” said Prof. Matteo Chiapasco from Milan, Italy. The addition of Geistlich Bio-Oss® 1g provides a convenient new size that bridges the gap between small and large procedures.

Geistlich Bio-Oss®, derived from bovine bone, preserves the native crystalline structure, which is highly similar to human bone, through a unique, patented technology. This manufacturing process ensures the vital building blocks are present to promote the initial biologic processes of cell adhesion and proliferation. The slow resorbing nature of Geistlich Bio-Oss® is a desirable characteristic that provides long-term volume preservation. As the body recognises and accepts these native crystalline structures, the particles become fully integrated into living bone.

The pairing of Geistlich Bio-Oss® with Geistlich Bio-Gide® in GBR treatments have been documented with clinical long-term success resulting in reliable 91.9 and 96 per cent implant survival rates.1,2 In addition to GBR, Geistlich Bio-Oss® and Geistlich Bio-Gide® has demonstrated the preservation of facial bone walls after five to nine years.3,4

The new package size Geistlich Bio-Oss® 1g is available in both small and large granule sizes.* – Geistlich Pharma North America, Inc.



  1. 1.      Jung R. et al. Clin Oral Implants Res. 2013 Oct;24(10):1065-73.
  2. 2.     Aghaloo TL, Moy PK. Int J Oral Maxillofac Implants. 2007;22 Suppl:49-70.
  3. 3.     Buser D. et al. J Periodontol. 2013 Nov;84(11):1517-27. doi: 10.1902/jop.2013.120635. Epub 2013 Jan 24.
  4. 4.     Jensen SS et al. J Periodontol. 2014 Nov;85(11):1549-56.

* Product availability can vary depending on the country